Found 33 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416448
(CHEMBL1209159)Show SMILES CC(C(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1ccccc1 |r| Show InChI InChI=1S/C23H24N4OS/c1-15(16-7-3-2-4-8-16)22(28)27-12-18-17(19(18)13-27)11-25-23-26-21(14-29-23)20-9-5-6-10-24-20/h2-10,14-15,17-19H,11-13H2,1H3,(H,25,26)/t15?,17-,18+,19- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.398 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416445
(CHEMBL1209162)Show SMILES O=C(CCc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C23H24N4OS/c28-22(10-9-16-6-2-1-3-7-16)27-13-18-17(19(18)14-27)12-25-23-26-21(15-29-23)20-8-4-5-11-24-20/h1-8,11,15,17-19H,9-10,12-14H2,(H,25,26)/t17-,18+,19- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.631 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416460
(CHEMBL1209345)Show SMILES Fc1cc(F)cc(CN2C[C@H]3[C@@H](CNc4nc(cs4)-c4ccccn4)[C@H]3C2)c1 |r| Show InChI InChI=1S/C21H20F2N4S/c22-14-5-13(6-15(23)7-14)9-27-10-17-16(18(17)11-27)8-25-21-26-20(12-28-21)19-3-1-2-4-24-19/h1-7,12,16-18H,8-11H2,(H,25,26)/t16-,17+,18- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.631 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416443
(CHEMBL1209216)Show SMILES O=C([C@H]1C[C@@H]1c1ccccc1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C24H24N4OS/c29-23(17-10-16(17)15-6-2-1-3-7-15)28-12-19-18(20(19)13-28)11-26-24-27-22(14-30-24)21-8-4-5-9-25-21/h1-9,14,16-20H,10-13H2,(H,26,27)/t16-,17+,18-,19+,20-/m1/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.794 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416447
(CHEMBL1209160)Show SMILES O=C(N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)C1(CC1)c1ccccc1 |r| Show InChI InChI=1S/C24H24N4OS/c29-22(24(9-10-24)16-6-2-1-3-7-16)28-13-18-17(19(18)14-28)12-26-23-27-21(15-30-23)20-8-4-5-11-25-20/h1-8,11,15,17-19H,9-10,12-14H2,(H,26,27)/t17-,18+,19- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.794 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416454
(CHEMBL1209052)Show SMILES Fc1cccc(c1)C(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C21H19FN4OS/c22-14-5-3-4-13(8-14)20(27)26-10-16-15(17(16)11-26)9-24-21-25-19(12-28-21)18-6-1-2-7-23-18/h1-8,12,15-17H,9-11H2,(H,24,25)/t15-,16+,17- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416450
(CHEMBL1209101)Show SMILES O=C(Cc1ccccc1)N1C[C@H]2[C@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C22H22N4OS/c27-21(10-15-6-2-1-3-7-15)26-12-17-16(18(17)13-26)11-24-22-25-20(14-28-22)19-8-4-5-9-23-19/h1-9,14,16-18H,10-13H2,(H,24,25)/t16-,17-,18+ | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416449
(CHEMBL1209102)Show SMILES O=C(Cc1ccccc1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C22H22N4OS/c27-21(10-15-6-2-1-3-7-15)26-12-17-16(18(17)13-26)11-24-22-25-20(14-28-22)19-8-4-5-9-23-19/h1-9,14,16-18H,10-13H2,(H,24,25)/t16-,17+,18- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416436
(CHEMBL1209346)Show SMILES CC(N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1ccccc1 |r| Show InChI InChI=1S/C22H24N4S/c1-15(16-7-3-2-4-8-16)26-12-18-17(19(18)13-26)11-24-22-25-21(14-27-22)20-9-5-6-10-23-20/h2-10,14-15,17-19H,11-13H2,1H3,(H,24,25)/t15?,17-,18+,19- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416453
(CHEMBL1209053)Show SMILES Fc1cc(F)cc(c1)C(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C21H18F2N4OS/c22-13-5-12(6-14(23)7-13)20(28)27-9-16-15(17(16)10-27)8-25-21-26-19(11-29-21)18-3-1-2-4-24-18/h1-7,11,15-17H,8-10H2,(H,25,26)/t15-,16+,17- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416438
(CHEMBL1209280)Show SMILES C(Nc1nc(cs1)-c1ccccn1)[C@@H]1[C@@H]2CN(Cc3ccccc3)C[C@H]12 |r| Show InChI InChI=1S/C21H22N4S/c1-2-6-15(7-3-1)11-25-12-17-16(18(17)13-25)10-23-21-24-20(14-26-21)19-8-4-5-9-22-19/h1-9,14,16-18H,10-13H2,(H,23,24)/t16-,17+,18- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416455
(CHEMBL1209051)Show SMILES O=C(N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1ccccc1 |r| Show InChI InChI=1S/C21H20N4OS/c26-20(14-6-2-1-3-7-14)25-11-16-15(17(16)12-25)10-23-21-24-19(13-27-21)18-8-4-5-9-22-18/h1-9,13,15-17H,10-12H2,(H,23,24)/t15-,16+,17- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416457
(CHEMBL1209049)Show SMILES CC(C)C(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C18H22N4OS/c1-11(2)17(23)22-8-13-12(14(13)9-22)7-20-18-21-16(10-24-18)15-5-3-4-6-19-15/h3-6,10-14H,7-9H2,1-2H3,(H,20,21)/t12-,13+,14- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416437
(CHEMBL1209281)Show SMILES Cc1cc(C)cc(CN2C[C@H]3[C@@H](CNc4nc(cs4)-c4ccccn4)[C@H]3C2)c1 |r| Show InChI InChI=1S/C23H26N4S/c1-15-7-16(2)9-17(8-15)11-27-12-19-18(20(19)13-27)10-25-23-26-22(14-28-23)21-5-3-4-6-24-21/h3-9,14,18-20H,10-13H2,1-2H3,(H,25,26)/t18-,19+,20- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416439
(CHEMBL1209279)Show SMILES CC(C)CN1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C18H24N4S/c1-12(2)8-22-9-14-13(15(14)10-22)7-20-18-21-17(11-23-18)16-5-3-4-6-19-16/h3-6,11-15H,7-10H2,1-2H3,(H,20,21)/t13-,14+,15- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 3.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416452
(CHEMBL1209100)Show SMILES O=C(N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1cccnc1 |r| Show InChI InChI=1S/C20H19N5OS/c26-19(13-4-3-6-21-8-13)25-10-15-14(16(15)11-25)9-23-20-24-18(12-27-20)17-5-1-2-7-22-17/h1-8,12,14-16H,9-11H2,(H,23,24)/t14-,15+,16- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416442
(CHEMBL1209218)Show SMILES O=C(C1CCCO1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(17-5-3-7-25-17)23-9-13-12(14(13)10-23)8-21-19-22-16(11-26-19)15-4-1-2-6-20-15/h1-2,4,6,11-14,17H,3,5,7-10H2,(H,21,22)/t12-,13+,14-,17? | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416444
(CHEMBL1209215)Show SMILES CC(C(C)c1ccccc1)C(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C25H28N4OS/c1-16(18-8-4-3-5-9-18)17(2)24(30)29-13-20-19(21(20)14-29)12-27-25-28-23(15-31-25)22-10-6-7-11-26-22/h3-11,15-17,19-21H,12-14H2,1-2H3,(H,27,28)/t16?,17?,19-,20+,21- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416446
(CHEMBL1209161)Show SMILES O=C(CCc1ccccc1)N1C[C@H]2[C@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C23H24N4OS/c28-22(10-9-16-6-2-1-3-7-16)27-13-18-17(19(18)14-27)12-25-23-26-21(15-29-23)20-8-4-5-11-24-20/h1-8,11,15,17-19H,9-10,12-14H2,(H,25,26)/t17-,18-,19+ | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 7.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416456
(CHEMBL1209050)Show SMILES O=C(N1C[C@H]2[C@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1ccccc1 |r| Show InChI InChI=1S/C21H20N4OS/c26-20(14-6-2-1-3-7-14)25-11-16-15(17(16)12-25)10-23-21-24-19(13-27-21)18-8-4-5-9-22-18/h1-9,13,15-17H,10-12H2,(H,23,24)/t15-,16-,17+ | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 12.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416459
(CHEMBL1209347)Show InChI InChI=1S/C15H10F3N3S/c16-15(17,18)10-4-6-11(7-5-10)20-14-21-13(9-22-14)12-3-1-2-8-19-12/h1-9H,(H,20,21) | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 15.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416441
(CHEMBL1209277)Show SMILES O=C(C1CCOCC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C20H24N4O2S/c25-19(13-4-7-26-8-5-13)24-10-15-14(16(15)11-24)9-22-20-23-18(12-27-20)17-3-1-2-6-21-17/h1-3,6,12-16H,4-5,7-11H2,(H,22,23)/t14-,15+,16- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 31.6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416451
(CHEMBL1208795)Show SMILES O=C(N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1)c1ccncc1 |r| Show InChI InChI=1S/C20H19N5OS/c26-19(13-4-7-21-8-5-13)25-10-15-14(16(15)11-25)9-23-20-24-18(12-27-20)17-3-1-2-6-22-17/h1-8,12,14-16H,9-11H2,(H,23,24)/t14-,15+,16- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 50.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416440
(CHEMBL1209278)Show SMILES C(Nc1nc(cs1)-c1ccccn1)[C@H]1[C@@H]2CNC[C@H]12 |r| Show InChI InChI=1S/C14H16N4S/c1-2-4-16-12(3-1)13-8-19-14(18-13)17-7-11-9-5-15-6-10(9)11/h1-4,8-11,15H,5-7H2,(H,17,18)/t9-,10+,11+ | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50416458
(CHEMBL1208996)Show SMILES CC(=O)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C16H18N4OS/c1-10(21)20-7-12-11(13(12)8-20)6-18-16-19-15(9-22-16)14-4-2-3-5-17-14/h2-5,9,11-13H,6-8H2,1H3,(H,18,19)/t11-,12+,13- | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50416459
(CHEMBL1209347)Show InChI InChI=1S/C15H10F3N3S/c16-15(17,18)10-4-6-11(7-5-10)20-14-21-13(9-22-14)12-3-1-2-8-19-12/h1-9H,(H,20,21) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y1 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50416459
(CHEMBL1209347)Show InChI InChI=1S/C15H10F3N3S/c16-15(17,18)10-4-6-11(7-5-10)20-14-21-13(9-22-14)12-3-1-2-8-19-12/h1-9H,(H,20,21) | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >3.16E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Antagonist activity at human NPY Y2 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assay |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C19 |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50323463
(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)Show SMILES O=C(C1CCOC1)N1C[C@H]2[C@@H](CNc3nc(cs3)-c3ccccn3)[C@H]2C1 |r| Show InChI InChI=1S/C19H22N4O2S/c24-18(12-4-6-25-10-12)23-8-14-13(15(14)9-23)7-21-19-22-17(11-26-19)16-3-1-2-5-20-16/h1-3,5,11-15H,4,6-10H2,(H,21,22)/t12?,13-,14+,15- | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description
Inhibition of CYP1A2 |
Bioorg Med Chem Lett 20: 4741-4 (2010)
Article DOI: 10.1016/j.bmcl.2010.06.140
BindingDB Entry DOI: 10.7270/Q2JS9QMP |
More data for this
Ligand-Target Pair | |
Search and Browse
